Divi's Laboratories
DIVISLAB
Quick Bite
Price To Earnings Ratio 97.45 | Sector PE 64.19 |
PB Ratio 11.49 | Sector PB 8.77 |
EPS 60.38 | Dividend Yield 0.87 |
Today's Volume 441.306 K | 5 Day Avg. Volume 338.679 K |
PEG Ratio -7.94 | Market Cap. ₹ 1,50,000.00 Cr. |
Returns Comparison
| Time | DIVISLAB | VS | Industry |
|---|---|---|---|
| 1 Day | 1.1% | -0.25% | |
| 1 Week | 3.66% | -1.97% | |
| 1 Month | 1.76% | -5.24% | |
| 6 Months | 44.15% | 13.56% | |
| 1 Year | 71.63% | 45.64% |
Technical Trend
Pivot Levels
Moving Averages
| Period (Days) | SMA | Indication |
|---|---|---|
| 10 | 5779.62 | Bullish |
| 20 | 5757.91 | Bullish |
| 30 | 5825.66 | Bullish |
| 50 | 5639.42 | Bullish |
| 100 | 5243.9 | Bullish |
| 200 | 4566.27 | Bullish |
Shareholding Updates
Cash Flow
| Annual | FY 2024 | FY 2023 | FY 2022 | ||||
|---|---|---|---|---|---|---|---|
| Operating Activities | 1261.00 | 2459.00 | 1911.80 | ||||
| Investing Activities | -269.00 | -2707.00 | -2194.92 | ||||
| Financing Activities | -799.00 | -797.00 | -532.44 | ||||
| Net Cash Flow | 193.00 | -1045.00 | -815.56 |
All Figures in ₹ Cr., unless mentioned otherwise
Ratios
Income Statement
Balance Sheet
Peer Comparison
| Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
|---|---|---|---|---|---|
| Divi's Laboratories | 1.1 | 3.66 | 1.76 | 44.15 | 71.63 |
| Aarti Drugs | -1.19 | -4.25 | -7.3 | -1.12 | 3.37 |
| Abbott India | 0.2 | -5.22 | -6.46 | -0.3 | 20.29 |
| Advanced Enzyme Tech | -1.49 | -5.52 | -17.71 | -4.78 | 13.63 |
| Ajanta Pharmaceuticals | 0.02 | 4.02 | -5.81 | 11.37 | 44.69 |
About Divi's Laboratories
Divi's Laboratories Share Price
Divi's Laboratories Limited is an Indian company that manufactures and markets active ingredients (APIs), intermediates and nutrients for export. The company's products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Naproxen Sodium, Olmesartan Medoxomil, Pregabalin, Ticagrelor, Triprolidine HCl, Valacyclovir HCl, Valsartan, Venlafaxine HCl and Vigabatrin. In addition to its generic business, the Company supports pharmaceutical companies through custom synthesis businesses in the commercialization of their proprietary products, from gram-scale requirements for clinical trials to launch and late life cycle management. The company's subsidiaries are Divis Laboratories (USA) Inc and Divi's Laboratories Europe AG.
Divi's Laboratories FAQs
How to Buy Divi's Laboratories Share?
What's Divi's Laboratories share price today?
What is the Market Cap of Divi's Laboratories?
What is the PE and PB ratio of Divi's Laboratories?
What is the 52 Week High and Low of Divi's Laboratories Share?